Medical Specialties Industry Financials, Performance and Ratios
-
Industry Score
46.5 /100
Rank 37 out of 131 Industries -
Advance/Decline
172/45
-
No. of Companies217
-
Avg. Market Cap8,258
-
Price to Earning Ratio28.72
-
Price to Earning Growth Ratio4.56
-
Price to Book Ratio5.75
-
Return on Equity16.93
-
Return on Capital Employed-
-
Return on Assets9.49
-
Dividend yield 1 year %0.20 %
-
Net Profit Growth Annual YoY %3.22 %
-
Net Profit Growth Qtr YoY %25.09 %
-
Net Profit Growth Qtr QoQ %3.06 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Medical Specialties Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Medical Specialties Peer comparison
Compare all stocks in Medical Specialties industry listed on stock exchanges
Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
---|---|---|---|---|---|---|---|---|---|---|---|
Agilent Technologies Inc. |
|
34,922.2
|
122.5
|
L
 1.1%
H
120.8
123.5
|
L
 -3.3%
H
117.2
126.7
|
L
 -9.0%
H
117.2
138.6
|
L
 -11.0%
H
117.2
153.8
|
L
 -16.9%
H
117.2
155.4
|
L
 -9.3%
H
96.8
160.3
|
L
 91.0%
H
62.1
179.6
|
L
 193.0%
H
33.1
179.6
|
Abbott Laboratories |
|
221,369.0
|
127.6
|
L
 0.7%
H
126.2
127.9
|
L
 -6.9%
H
124.5
139.2
|
L
 -2.3%
H
124.5
141.2
|
L
 12.8%
H
110.9
141.2
|
L
 10.5%
H
99.7
141.2
|
L
 6.8%
H
89.7
141.2
|
L
 73.3%
H
61.6
142.6
|
L
 166.9%
H
36
142.6
|
Alcon Inc. - Registered Sh... |
|
44,446.2
|
89.9
|
L
 1.0%
H
88.7
90.3
|
L
 -3.4%
H
86.8
91.9
|
L
 -0.2%
H
86.8
95.4
|
L
 7.1%
H
82.3
95.4
|
L
 5.7%
H
77.5
101.1
|
L
 20.0%
H
55.2
101.1
|
L
 88.5%
H
39.4
101.1
|
L
H
39.4
101.1
|
Artivion Inc |
|
1,012.5
|
24.1
|
L
 -0.2%
H
24.0
24.5
|
L
 -0.4%
H
22.9
24.5
|
L
 -19.9%
H
22.9
30.1
|
L
 -16.9%
H
22.9
32.3
|
L
 21.9%
H
19.4
32.3
|
L
 18.1%
H
9.6
32.3
|
L
 28.5%
H
9.6
32.3
|
L
 128.2%
H
8.9
36.1
|
Avanos Medical Inc |
|
672.1
|
14.6
|
L
 1.0%
H
14.4
14.9
|
L
 -4.1%
H
14.3
15.5
|
L
 -11.8%
H
14.3
16.8
|
L
 -17.7%
H
14.3
17.8
|
L
 -23.5%
H
14.3
25.4
|
L
 -54.6%
H
14.3
34.8
|
L
 -42.0%
H
14.3
53.6
|
L
 -68.7%
H
14.3
73.0
|
Baxter International Inc. |
|
17,830.1
|
34.9
|
L
 0.8%
H
34.4
35.0
|
L
 -4.7%
H
34.1
37.7
|
L
 13.1%
H
30.6
37.7
|
L
 18.5%
H
28.3
37.7
|
L
 -16.3%
H
28.3
44.0
|
L
 -55.9%
H
28.3
80.7
|
L
 -51.3%
H
28.3
95.2
|
L
 -6.2%
H
28.3
95.2
|
Becton, Dickinson And Co. |
|
65,418.1
|
227.8
|
L
 0.8%
H
225.1
228.8
|
L
 -0.7%
H
222.0
235.3
|
L
 1.4%
H
221.7
235.3
|
L
 0.1%
H
221.7
251.9
|
L
 -3.8%
H
218.8
251.9
|
L
 -10.5%
H
215.9
287.3
|
L
 4.7%
H
192.9
287.3
|
L
 64.1%
H
125.7
287.3
|
Butterfly Network Inc - Or... |
|
665.6
|
2.7
|
L
 2.2%
H
2.7
2.9
|
L
 -3.9%
H
2.5
2.9
|
L
 -42.6%
H
2.5
5.0
|
L
 -20.8%
H
2.5
5.0
|
L
 156.1%
H
0.7
5.0
|
L
 -46.0%
H
0.7
8.7
|
L
H
0.7
29.1
|
L
H
0.7
29.1
|
Bio-Rad Laboratories Inc. ... |
|
7,198.9
|
257
|
L
 1%
H
250.9
257.8
|
L
 -1.6%
H
244
260.9
|
L
 -7.3%
H
244
290.0
|
L
 -25.1%
H
244
373.7
|
L
 -22.9%
H
244
388.0
|
L
 -54.3%
H
244
607.5
|
L
 -23.4%
H
244
832.7
|
L
 88.9%
H
122.0
832.7
|
Bausch + Lomb Corp |
|
5,428.1
|
15.4
|
L
 0.3%
H
15.3
15.5
|
L
 -4.4%
H
15.1
16.1
|
L
 -6.2%
H
15.1
16.6
|
L
 -17.0%
H
15.1
19.0
|
L
 -3.5%
H
13.2
21.7
|
L
H
12.2
22.0
|
L
H
12.2
22.0
|
L
H
12.2
22.0
|
Conmed Corp. |
|
1,897.5
|
61.4
|
L
 4.4%
H
58.7
62.4
|
L
 -2.2%
H
58.2
64.9
|
L
 -2.8%
H
55.2
64.9
|
L
 -13.9%
H
55.2
74.7
|
L
 -20.7%
H
55.2
81.2
|
L
 -56.7%
H
55.2
155.5
|
L
 5.2%
H
37.7
159.1
|
L
 19.0%
H
35.5
159.1
|
Cooper Companies, Inc. |
|
15,978.6
|
79.9
|
L
 -1.6%
H
79.6
81.6
|
L
 -6.0%
H
77.1
85.3
|
L
 -9.3%
H
77.1
92.8
|
L
 -15.0%
H
77.1
100.2
|
L
 -20.7%
H
77.1
112.4
|
L
 -21.5%
H
61.1
112.4
|
L
 23.2%
H
59.2
115.9
|
L
 69.9%
H
29.8
115.9
|
Danaher Corp. |
|
151,947.3
|
212.6
|
L
 0.9%
H
210.9
213.8
|
L
 0.3%
H
202.7
213.8
|
L
 3.1%
H
201.2
216.2
|
L
 -10.1%
H
196.8
258.2
|
L
 -14.8%
H
196.8
281.7
|
L
 -23.5%
H
182.1
303.8
|
L
 66.6%
H
119.6
334.0
|
L
 223.1%
H
61.6
334.0
|
Edwards Lifesciences Corp |
|
41,523.4
|
70.6
|
L
 1.9%
H
68.6
71.1
|
L
 0.4%
H
67.3
71.1
|
L
 -7.3%
H
67.3
76.7
|
L
 -4.4%
H
67.3
76.7
|
L
 -23.5%
H
58.9
96.1
|
L
 -35.7%
H
58.9
131.1
|
L
 27.9%
H
51.5
131.7
|
L
 185.1%
H
20.5
131.7
|
Paragon 28 Inc |
|
1,091.5
|
13.0
|
L
 -0.2%
H
13
13.0
|
L
 -0.2%
H
13
13.1
|
L
 -0.4%
H
12.9
13.1
|
L
 21.6%
H
9.4
13.1
|
L
 42.7%
H
4.7
13.1
|
L
 -26.3%
H
4.7
21.5
|
L
H
4.7
25.4
|
L
H
4.7
25.4
|
Glaukos Corporation |
|
5,846.2
|
103.4
|
L
 1.1%
H
101.6
104.5
|
L
 -0.8%
H
91.8
104.5
|
L
 -32.5%
H
91.8
161.8
|
L
 -28.3%
H
91.8
163.7
|
L
 20.9%
H
85.0
163.7
|
L
 93.4%
H
33.3
163.7
|
L
 209.9%
H
23.3
163.7
|
L
H
14.3
163.7
|
Globus Medical Inc - Ordin... |
|
9,922.3
|
72.1
|
L
 1.6%
H
70.6
72.8
|
L
 -6.8%
H
68.9
76.8
|
L
 -14.1%
H
68.9
85.5
|
L
 -11.7%
H
68.9
94.9
|
L
 40.4%
H
49.3
94.9
|
L
 7.4%
H
43.4
94.9
|
L
 105.8%
H
34.8
94.9
|
L
 190.9%
H
19.3
94.9
|
Haemonetics Corp. |
|
3,255.4
|
64.8
|
L
 -1.1%
H
64.4
65.8
|
L
 -5.7%
H
64.4
70.1
|
L
 3.9%
H
61.6
70.1
|
L
 -21.2%
H
58.8
83.3
|
L
 -13.4%
H
58.8
98.0
|
L
 17.3%
H
48.7
98.0
|
L
 -24.3%
H
43.5
142.1
|
L
 47.9%
H
26.0
142.1
|
Inspire Medical Systems Inc |
|
4,942.6
|
166.6
|
L
 2.7%
H
161.8
166.9
|
L
 -9.1%
H
156.9
189.5
|
L
 -10.3%
H
156.9
197.8
|
L
 -11.8%
H
156.9
216.0
|
L
 -13.6%
H
123
257.4
|
L
 -25.8%
H
123
330
|
L
 223.4%
H
40.5
330
|
L
H
22.5
330
|
Integer Holdings Corp |
|
4,010.9
|
119.3
|
L
 1.2%
H
117.3
120.2
|
L
 -2.2%
H
114.6
122.2
|
L
 -15.4%
H
114.6
144.8
|
L
 -13.8%
H
114.6
146.4
|
L
 4.8%
H
107.1
146.4
|
L
 49.9%
H
50.1
146.4
|
L
 88.4%
H
46.0
146.4
|
L
 138.5%
H
18.1
146.4
|
Medtronic Plc |
|
119,725.4
|
93.4
|
L
 0.3%
H
92.8
93.7
|
L
 -1.2%
H
90.4
96.3
|
L
 0.6%
H
85.1
96.3
|
L
 14.8%
H
79.3
96.3
|
L
 11.7%
H
76.0
96.3
|
L
 -13.0%
H
68.9
114.3
|
L
 20.6%
H
68.9
135.9
|
L
 20.2%
H
55.5
135.9
|
Mettler-Toledo Internation... |
|
25,832.2
|
1,235.0
|
L
 0.4%
H
1220.5
1249.0
|
L
 -4.4%
H
1200.1
1311.3
|
L
 -2.9%
H
1200.1
1324.4
|
L
 -2.0%
H
1197.1
1438.5
|
L
 -6.8%
H
1142.9
1546.9
|
L
 -9.1%
H
928.5
1616.0
|
L
 98.4%
H
579.4
1714.8
|
L
 285.1%
H
275.3
1714.8
|
Nevro Corp |
|
221.8
|
5.8
|
L
 -0.3%
H
5.8
5.8
|
L
 0.2%
H
5.7
5.8
|
L
 1.2%
H
5.7
5.8
|
L
 39.3%
H
3.2
5.8
|
L
 -57.9%
H
3.2
14.7
|
L
 -91.2%
H
3.2
78.9
|
L
 -93.4%
H
3.2
188.1
|
L
 -86.9%
H
3.2
188.1
|
Envista Holdings Corp |
|
2,956.5
|
17.2
|
L
 3.1%
H
16.5
17.3
|
L
 -6.8%
H
16.1
18.3
|
L
 -20.6%
H
16.1
22.2
|
L
 -12.3%
H
16.1
22.7
|
L
 -19.6%
H
15.1
23
|
L
 -64.1%
H
15.1
52.0
|
L
 0.8%
H
10.1
52.0
|
L
H
10.1
52.0
|
Owens & Minor, Inc. |
|
762.4
|
9.9
|
L
 5.1%
H
9.4
9.9
|
L
 -1.3%
H
9.2
9.9
|
L
 32.5%
H
6.1
10.4
|
L
 -27.6%
H
6.1
15.5
|
L
 -61.3%
H
6.1
28.4
|
L
 -78.0%
H
6.1
47.2
|
L
 103.1%
H
4.8
49.2
|
L
 -70.7%
H
2.4
49.2
|
Penumbra Inc |
|
10,633.1
|
276.1
|
L
 1.3%
H
268.9
278.3
|
L
 0.5%
H
254.5
278.3
|
L
 2.8%
H
254.5
310
|
L
 11.7%
H
222.6
310
|
L
 24.3%
H
148
310
|
L
 37.1%
H
114.9
348.7
|
L
 96.0%
H
114.9
348.7
|
L
H
30
348.7
|
Koninklijke Philips N.V. -... |
|
24,827.2
|
26.8
|
L
 0.3%
H
26.6
27.0
|
L
 -2.6%
H
26.1
27.2
|
L
 -4.8%
H
24.5
28.4
|
L
 4.6%
H
24.5
28.7
|
L
 27.5%
H
19.8
32.9
|
L
 -16.4%
H
11.8
32.9
|
L
 -14.1%
H
11.8
61.2
|
L
 -5.0%
H
11.8
61.2
|
Qiagen NV |
|
8,605.7
|
39.8
|
L
 0.9%
H
39.3
40
|
L
 0.2%
H
38.8
40
|
L
 -0.1%
H
37.6
40.2
|
L
 -14.7%
H
37.6
49.3
|
L
 -12.1%
H
37.6
49.3
|
L
 -20.2%
H
36.8
54.3
|
L
 -4.8%
H
36.8
62.6
|
L
 42.0%
H
22.0
62.6
|
Vicarious Surgical Inc - O... |
|
56.9
|
9.6
|
L
 8.2%
H
8.9
9.7
|
L
 3.6%
H
8.3
9.7
|
L
 -35.8%
H
8.3
16.4
|
L
 -32.6%
H
8.3
18.8
|
L
 -97.2%
H
4.3
396
|
L
 -99.8%
H
4.3
5400
|
L
H
4.3
14207.0
|
L
H
4.3
14207.0
|
Resmed Inc. |
|
33,006.9
|
224.7
|
L
 0.3%
H
220.8
227.0
|
L
 -3.3%
H
217.5
243.4
|
L
 -3.5%
H
217.5
243.4
|
L
 -6.8%
H
217.5
263.1
|
L
 18.3%
H
172.2
263.1
|
L
 -12.0%
H
132.2
263.1
|
L
 62.9%
H
108.9
301.3
|
L
 216.4%
H
49.0
301.3
|
Steris Plc |
|
22,382.5
|
227.8
|
L
 0.5%
H
225.8
229.1
|
L
 -2.1%
H
221.4
236.8
|
L
 3.9%
H
214.8
236.8
|
L
 8.0%
H
201.0
236.8
|
L
 -1.0%
H
197.8
248.2
|
L
 0.3%
H
159.2
255.9
|
L
 89.1%
H
105.7
255.9
|
L
 235.2%
H
60.8
255.9
|
Stevanato Group Spa |
|
5,616.3
|
20.6
|
L
 2.8%
H
19.9
20.8
|
L
 -4.6%
H
19.4
22.7
|
L
 5.3%
H
17.8
22.7
|
L
 -11.8%
H
17.8
24.4
|
L
 -31.4%
H
16.6
33.5
|
L
 25.0%
H
13.4
36.3
|
L
H
13.4
36.3
|
L
H
13.4
36.3
|
Stryker Corp. |
|
142,516.0
|
373.5
|
L
 1.1%
H
368
376.7
|
L
 -1.5%
H
361.0
377.1
|
L
 -3.0%
H
361.0
398
|
L
 -0.2%
H
351.9
406.2
|
L
 6.0%
H
314.9
406.2
|
L
 42.5%
H
188.8
406.2
|
L
 159.7%
H
124.5
406.2
|
L
 302.6%
H
86.7
406.2
|
Smith & Nephew plc - ADR |
|
12,679.0
|
29.0
|
L
 1.6%
H
28.7
30.0
|
L
 -2.8%
H
28.2
30.1
|
L
 13.0%
H
25.5
30.4
|
L
 14.7%
H
23.7
30.4
|
L
 7.5%
H
23.7
31.7
|
L
 -12.1%
H
21.5
34.1
|
L
 -2.2%
H
21.5
46.1
|
L
 -14.7%
H
21.5
52.3
|
Teleflex Incorporated |
|
6,479.7
|
139.8
|
L
 1.5%
H
136.7
139.8
|
L
 -0.1%
H
134.4
143.1
|
L
 -16.5%
H
128.6
180.6
|
L
 -23.2%
H
128.6
185.9
|
L
 -35.1%
H
128.6
249.9
|
L
 -59.0%
H
128.6
356.7
|
L
 -50.6%
H
128.6
449.4
|
L
 16.4%
H
118.4
449.4
|
Thermo Fisher Scientific Inc. |
|
196,013.6
|
519.6
|
L
 -0.5%
H
514.7
525.7
|
L
 -2.3%
H
508.4
536.2
|
L
 -2.3%
H
508.4
543.8
|
L
 -2.0%
H
508.4
611.0
|
L
 -11.1%
H
493.3
627.9
|
L
 -7.6%
H
415.6
627.9
|
L
 86.0%
H
250.2
672.3
|
L
 290.7%
H
117.1
672.3
|
Waters Corp. |
|
22,512.0
|
378.9
|
L
 0.5%
H
376.2
384.0
|
L
 -3.6%
H
360.3
400.0
|
L
 2.5%
H
360.3
400.0
|
L
 1.3%
H
354.4
423.6
|
L
 7.4%
H
279.2
423.6
|
L
 15.9%
H
231.9
423.6
|
L
 117.9%
H
154.4
428.2
|
L
 204.1%
H
112
428.2
|
West Pharmaceutical Servic... |
|
16,735.4
|
231.5
|
L
 0.6%
H
229.9
234.4
|
L
H
220.5
234.4
|
L
 7.8%
H
201.3
236.7
|
L
 -30.0%
H
197.0
348.9
|
L
 -40.3%
H
197.0
400.9
|
L
 -41.7%
H
197.0
424
|
L
 77.4%
H
124.5
475.4
|
L
 316.0%
H
52.7
475.4
|
Zimmer Biomet Holdings Inc |
|
22,253.3
|
111.8
|
L
 1.7%
H
109.1
112.9
|
L
 3.5%
H
103.5
112.9
|
L
 11.2%
H
99.4
112.9
|
L
 4.6%
H
97.7
113.8
|
L
 -10.7%
H
97.7
133.9
|
L
 -8.4%
H
97.7
149.3
|
L
 29.1%
H
70.0
169.7
|
L
 0.6%
H
70.0
169.7
|
Bio-Rad Laboratories Inc. ... |
|
7,652.7
|
265.8
|
L
H
265.8
265.8
|
L
H
265.8
265.8
|
L
 -14.8%
H
265.8
265.8
|
L
 -21.1%
H
265.8
359.2
|
L
 -20.0%
H
265.8
373.4
|
L
 -20.0%
H
265.8
373.4
|
L
 -20.0%
H
265.8
373.4
|
L
 -20.0%
H
265.8
373.4
|
Revvity Inc. |
|
13,601.9
|
113.2
|
L
 1.2%
H
111.6
114.3
|
L
 -3.7%
H
110.0
120.4
|
L
 0.9%
H
106.6
120.4
|
L
 -1.7%
H
106.6
128.3
|
L
 7.9%
H
97.3
129.5
|
L
 -35.7%
H
79.5
184.8
|
L
 69.7%
H
62.9
203.2
|
L
 134.4%
H
39.5
203.2
|
Aethlon Medical Inc |
|
5.5
|
0.4
|
L
 2.7%
H
0.4
0.4
|
L
 -13.6%
H
0.4
0.5
|
L
 -38.7%
H
0.4
0.7
|
L
 8.6%
H
0.3
1.1
|
L
 -78.0%
H
0.2
1.9
|
L
 -97.1%
H
0.2
24.6
|
L
 -96.9%
H
0.2
124.9
|
L
 -100.0%
H
0.2
2287.5
|
Acutus Medical Inc |
|
1.5
|
0.1
|
L
H
0.0
0.1
|
L
H
0.0
0.1
|
L
H
0.0
0.1
|
L
 -16.7%
H
0.0
0.1
|
L
 -75%
H
0.0
0.3
|
L
 -97.1%
H
0.0
2.2
|
L
H
0.0
39.0
|
L
H
0.0
39.0
|
Ainos Inc |
|
8.0
|
0.5
|
L
H
0.5
0.6
|
L
 6.1%
H
0.4
0.6
|
L
 -29.7%
H
0.4
0.7
|
L
 20.9%
H
0.4
1
|
L
 -57.0%
H
0.4
1.5
|
L
 -94.5%
H
0.4
18
|
L
H
0
71.3
|
L
H
0
71.3
|
Airsculpt Technologies Inc |
|
152.2
|
2.6
|
L
 -8.0%
H
2.6
3.0
|
L
 -22.7%
H
2.4
3.7
|
L
 -54.3%
H
2.4
6.1
|
L
 -56.1%
H
2.4
6.6
|
L
 -54.3%
H
2.4
9.2
|
L
 -79.7%
H
2.4
14.6
|
L
H
2.4
18.5
|
L
H
2.4
18.5
|
Align Technology, Inc. |
|
12,481.4
|
169.6
|
L
 2.0%
H
165.3
171.5
|
L
 -2.4%
H
158.1
172
|
L
 -18.0%
H
158.1
207.4
|
L
 -28.2%
H
158.1
237.2
|
L
 -46.1%
H
158.1
335.2
|
L
 -59.7%
H
158.1
461.8
|
L
 4.9%
H
127.9
737.5
|
L
 201.0%
H
51.7
737.5
|
Angiodynamic Inc |
|
388.1
|
9.6
|
L
 6.4%
H
9
9.8
|
L
 5.4%
H
8.3
9.8
|
L
 -7.3%
H
8.3
11.1
|
L
 2.8%
H
8.3
13.5
|
L
 78.6%
H
5.3
13.5
|
L
 -58.2%
H
5.3
24.9
|
L
 11.3%
H
5.3
32
|
L
 -47.0%
H
5.3
32
|
Anika Therapeutics Inc. |
|
235.9
|
16.1
|
L
 1.3%
H
15.6
16.7
|
L
 -3.1%
H
15.0
17.1
|
L
 -9.8%
H
15.0
18.3
|
L
 -4.9%
H
15.0
18.4
|
L
 -36.7%
H
15.0
29.1
|
L
 -38.6%
H
15.0
32.5
|
L
 -39.8%
H
15.0
48.4
|
L
 -59.9%
H
15.0
75.7
|
Apyx Medical Corp |
|
42.5
|
1.1
|
L
 13%
H
1.0
1.2
|
L
 -5.0%
H
0.9
1.2
|
L
 -24.7%
H
0.9
1.6
|
L
 -32.7%
H
0.9
1.8
|
L
 -36.9%
H
0.9
2.0
|
L
 -83.7%
H
0.9
11.2
|
L
 -75.4%
H
0.9
17.5
|
L
 -54.8%
H
0.9
17.5
|
Accuray Inc |
|
192.3
|
1.9
|
L
 2.2%
H
1.8
1.9
|
L
 0.5%
H
1.7
1.9
|
L
 -16.1%
H
1.7
2.3
|
L
 -4.1%
H
1.7
3.0
|
L
 -28.4%
H
1.4
3.0
|
L
 -45.6%
H
1.4
4.3
|
L
 29.9%
H
1.3
6.0
|
L
 -78.6%
H
1.3
10.0
|
Alphatec Holdings Inc |
|
1,405.5
|
9.8
|
L
 5.0%
H
9.3
9.9
|
L
 -6.8%
H
9.1
10.4
|
L
 -9.2%
H
9.1
12.8
|
L
 3.0%
H
8.7
12.8
|
L
 -25.5%
H
4.9
14.9
|
L
 -7.8%
H
4.9
19.1
|
L
 193.7%
H
2.2
19.4
|
L
 -44.3%
H
1.2
19.4
|
Atricure Inc |
|
1,651.2
|
33.8
|
L
 1.4%
H
32.7
33.8
|
L
 -2.1%
H
32.3
34.5
|
L
 -17.5%
H
32.3
40.8
|
L
 7.1%
H
29.6
43.1
|
L
 5.1%
H
18.9
43.1
|
L
 -46.2%
H
18.9
68.6
|
L
 33.3%
H
18.9
89.2
|
L
 71.8%
H
13.4
89.2
|
Accelerate Diagnostics Inc |
|
27.3
|
1.1
|
L
 -5.2%
H
1.1
1.1
|
L
 -2.7%
H
1.1
1.2
|
L
 -7.6%
H
1.0
1.2
|
L
 -9.2%
H
1.0
1.4
|
L
 14.7%
H
0.7
2.1
|
L
 -94.3%
H
0.7
37.4
|
L
 -98.7%
H
0.7
191.1
|
L
 -99.5%
H
0.7
312.9
|
Axogen Inc. |
|
810.6
|
18.3
|
L
 6.0%
H
17.3
18.4
|
L
 3.1%
H
16.8
18.4
|
L
 0.8%
H
16.2
21
|
L
 28.3%
H
14.0
21
|
L
 138.0%
H
5.6
21
|
L
 122.9%
H
3.5
21
|
L
 112.3%
H
3.5
23.9
|
L
 439.2%
H
3.0
56.9
|
Bone Biologics Corp |
|
2.7
|
0.8
|
L
H
0.8
0.9
|
L
 -1.2%
H
0.8
0.9
|
L
 -20.2%
H
0.7
1.3
|
L
 -26.6%
H
0.7
1.3
|
L
 -64.4%
H
0.7
4.3
|
L
 -99.8%
H
0.7
976.8
|
L
 -100.0%
H
0.7
4500.1
|
L
H
0.7
35400
|
BioAffinity Technologies Inc |
|
5.2
|
0.3
|
L
 -21.6%
H
0.3
0.4
|
L
 -21.6%
H
0.3
0.5
|
L
 -63.8%
H
0.3
0.9
|
L
 -67.1%
H
0.3
1.3
|
L
 -84.7%
H
0.3
3.2
|
L
H
0.3
15.6
|
L
H
0.3
15.6
|
L
H
0.3
15.6
|
Bluejay Diagnostics Inc |
|
2.3
|
4.1
|
L
 0.7%
H
3.9
4.2
|
L
 -2.9%
H
3.6
4.3
|
L
 13.4%
H
3.3
5.0
|
L
 -14.0%
H
3.3
5.4
|
L
 -36.4%
H
0.1
7.2
|
L
 -97.8%
H
0.1
292.8
|
L
H
0.1
1000
|
L
H
0.1
1000
|
Biolife Solutions Inc |
|
1,215.8
|
25.9
|
L
 3.7%
H
24.8
26.0
|
L
 0.4%
H
24.1
27.1
|
L
 -6.7%
H
23.4
28.9
|
L
 -5.4%
H
23.4
29.5
|
L
 49.7%
H
14.8
29.5
|
L
 20.6%
H
8.9
29.5
|
L
 210.0%
H
8.3
60.7
|
L
 1509.9%
H
1.4
60.7
|
Biomerica Inc. |
|
12.8
|
0.7
|
L
 12.9%
H
0.6
0.7
|
L
 9.4%
H
0.6
0.7
|
L
 -15.7%
H
0.6
1.1
|
L
 133.3%
H
0.3
1.3
|
L
 -34.0%
H
0.2
1.3
|
L
 -80.8%
H
0.2
5.3
|
L
 -71.1%
H
0.2
23.4
|
L
 -7.9%
H
0.2
23.4
|
Bruker Corp |
|
7,121.0
|
46.9
|
L
 2.1%
H
45.8
47.4
|
L
 -3.0%
H
44.1
48.7
|
L
 -6.2%
H
44.1
54.5
|
L
 -17.9%
H
44.1
64.6
|
L
 -49.0%
H
44.1
94.9
|
L
 -29.2%
H
44.1
94.9
|
L
 47.2%
H
30.8
94.9
|
L
 143.2%
H
15.8
94.9
|
BioRestorative Therapies Inc |
|
11.6
|
1.7
|
L
 -5.7%
H
1.6
1.8
|
L
 7.7%
H
1.5
1.8
|
L
 -27.1%
H
1.4
2.4
|
L
 14.4%
H
1.4
2.6
|
L
 25.6%
H
1.0
2.6
|
L
 -57.3%
H
1.0
7.1
|
L
 4.4%
H
0.4
185.6
|
L
 -100.0%
H
0.4
49000
|
Biosig Technologies Inc |
|
16.2
|
0.7
|
L
 11.5%
H
0.6
0.7
|
L
 -12.8%
H
0.5
0.9
|
L
 -27.7%
H
0.5
1.2
|
L
 -57.5%
H
0.5
1.7
|
L
 28.3%
H
0.2
3.0
|
L
 -37.6%
H
0.1
3.0
|
L
 -74.1%
H
0.1
12.4
|
L
 -85.3%
H
0.1
12.4
|
Bioventus Inc - Ordinary S... |
|
648.3
|
9.8
|
L
 2.0%
H
9.5
10.0
|
L
 6.5%
H
8.4
11.3
|
L
 -5.9%
H
8.4
11.3
|
L
 -12.1%
H
8.4
11.6
|
L
 79.8%
H
3.9
14.4
|
L
 -28.8%
H
0.8
14.7
|
L
H
0.8
19.9
|
L
H
0.8
19.9
|
Brainsway Ltd - ADR |
|
192.2
|
10.2
|
L
H
10.0
10.4
|
L
 8.5%
H
9.0
10.5
|
L
 -9.7%
H
8.9
11.8
|
L
 7.4%
H
8.8
11.8
|
L
 75.7%
H
4.6
11.8
|
L
 36.9%
H
1.4
11.8
|
L
 63.6%
H
1.4
11.8
|
L
H
1.4
12.5
|
Cardio Diagnostics Holding... |
|
24.0
|
0.5
|
L
 9.5%
H
0.4
0.5
|
L
 2.2%
H
0.4
0.5
|
L
 -31.3%
H
0.4
0.7
|
L
 -64.6%
H
0.4
1.3
|
L
 -63.5%
H
0.2
1.8
|
L
 -95.3%
H
0.2
10.3
|
L
H
0.2
10.3
|
L
H
0.2
10.3
|
Caredx Inc |
|
1,068.1
|
19.3
|
L
 2.0%
H
18.6
19.3
|
L
 1.9%
H
17.5
19.3
|
L
 -21.4%
H
17.5
25.6
|
L
 -15.7%
H
17.5
26.0
|
L
 90.0%
H
7.4
34.8
|
L
 -42.6%
H
4.8
41.5
|
L
 17.8%
H
4.8
99.8
|
L
 194.6%
H
0.8
99.8
|
Celcuity Inc |
|
380.6
|
10.3
|
L
 2.2%
H
9.9
10.4
|
L
 -3.7%
H
9.6
11
|
L
 -20.4%
H
8.5
13.4
|
L
 -18.3%
H
8.5
13.9
|
L
 -42.3%
H
8.5
22.2
|
L
 29.3%
H
4.8
22.2
|
L
 77.0%
H
4.0
33.0
|
L
H
4.0
33.0
|
Creative Medical Technolog... |
|
5.6
|
3.2
|
L
 -1.8%
H
2.9
3.3
|
L
 -22.7%
H
2.9
4.3
|
L
 -32.3%
H
2.9
6.9
|
L
 37.2%
H
2.0
6.9
|
L
 -40.1%
H
2.0
6.9
|
L
 -81.1%
H
2.0
51.5
|
L
 -92.2%
H
2.0
650
|
L
H
2.0
525000
|
Cerus Corp. |
|
269.4
|
1.5
|
L
H
1.4
1.5
|
L
 -4.0%
H
1.4
1.5
|
L
 -21.6%
H
1.4
2.0
|
L
 -17.6%
H
1.4
2.2
|
L
 -24.1%
H
1.4
2.5
|
L
 -72.6%
H
1.2
6.0
|
L
 -60.2%
H
1.2
8.9
|
L
 -66.0%
H
1.2
8.9
|
Check-Cap Ltd |
|
4.6
|
0.8
|
L
 2.6%
H
0.7
0.9
|
L
 -1.3%
H
0.7
0.9
|
L
 -8.1%
H
0.7
1.5
|
L
 27.4%
H
0.6
3.0
|
L
 -58.2%
H
0.6
3.5
|
L
 -89.7%
H
0.6
9.2
|
L
 -96.7%
H
0.6
89.8
|
L
H
0.6
284544
|
CollPlant Biotechnologies ... |
|
36.4
|
3.2
|
L
 -2.8%
H
3.2
3.3
|
L
 -4.8%
H
3.1
3.3
|
L
 -11.7%
H
3
3.7
|
L
 -12.2%
H
3
4.6
|
L
 -36.5%
H
3
6.8
|
L
 -68.9%
H
3
14.8
|
L
 -67.6%
H
3
24.3
|
L
H
3
27.9
|
ClearPoint Neuro Inc |
|
375.8
|
13.6
|
L
 6.3%
H
12.8
13.8
|
L
 4.1%
H
11.9
13.8
|
L
 -25.8%
H
11.9
18.9
|
L
 -15.1%
H
11.9
19.2
|
L
 90.2%
H
5.1
19.2
|
L
 58.1%
H
4.1
19.2
|
L
 240.9%
H
2.9
31.3
|
L
 -58.9%
H
1.3
58.4
|
Cardiff Oncology Inc |
|
269.4
|
4.1
|
L
 1.3%
H
3.9
4.1
|
L
 4.9%
H
3.5
4.4
|
L
 -5.6%
H
3.5
5.0
|
L
 5.7%
H
3.3
5.6
|
L
 -19.5%
H
2.0
6.4
|
L
 64.0%
H
0.9
6.4
|
L
 365.5%
H
0.7
25.5
|
L
 -99.2%
H
0.7
977.8
|
Castle Biosciences Inc |
|
571.1
|
20.0
|
L
 3.8%
H
19.1
20.3
|
L
 -0.9%
H
18.7
20.5
|
L
 -26.7%
H
18.7
27.8
|
L
 -31.2%
H
18.7
32.7
|
L
 6.3%
H
17.0
35.8
|
L
 -51.6%
H
9.3
47.3
|
L
 -13.2%
H
9.3
107.7
|
L
H
9.3
107.7
|
Cytek BioSciences Inc |
|
558.5
|
4.4
|
L
 3.8%
H
4.2
4.5
|
L
 -3.8%
H
4.1
4.6
|
L
 -16.6%
H
4.1
5.4
|
L
 -33.7%
H
4.1
7.3
|
L
 -37.3%
H
4.1
7.6
|
L
 -64.8%
H
3.8
16.1
|
L
H
3.8
28.7
|
L
H
3.8
28.7
|
Cytosorbents Corp |
|
70.5
|
1.1
|
L
 2.7%
H
1.1
1.2
|
L
 11.9%
H
1.0
1.2
|
L
 -13.1%
H
1.0
1.3
|
L
 24.2%
H
0.8
1.6
|
L
 28.4%
H
0.7
1.6
|
L
 -62.8%
H
0.7
4.6
|
L
 -75.2%
H
0.7
11.7
|
L
 -91.2%
H
0.7
15.2
|
Citius Pharmaceuticals Inc |
|
13.1
|
1.5
|
L
 2%
H
1.5
1.6
|
L
 -14.5%
H
1.5
1.9
|
L
 -43.1%
H
1.5
3.0
|
L
 -40.7%
H
1.5
6.0
|
L
 -91.7%
H
0.1
26.8
|
L
 -96.2%
H
0.1
50.3
|
L
 -87.8%
H
0.1
114
|
L
 -99.8%
H
0.1
937.5
|
CVRx Inc |
|
305.9
|
11.8
|
L
 2.7%
H
11.2
11.8
|
L
 1.6%
H
10.8
12.0
|
L
 -22.1%
H
10.8
15.4
|
L
 -12.2%
H
10.8
18.6
|
L
 -43.6%
H
6.4
21.7
|
L
 89.5%
H
4.6
33.1
|
L
H
4.6
33.1
|
L
H
4.6
33.1
|
Delcath Systems Inc |
|
440.6
|
13.2
|
L
 4.9%
H
12.4
13.5
|
L
 1.5%
H
11.1
13.5
|
L
 -19.0%
H
11.1
16.4
|
L
 -0.5%
H
10.8
17.0
|
L
 232.2%
H
3.9
17.0
|
L
 123.6%
H
2.3
17.0
|
L
 44.9%
H
2.3
25.2
|
L
 -100.0%
H
2.3
3763200000
|
Alpha Tau Medical Ltd |
|
186.5
|
2.7
|
L
 0.4%
H
2.6
2.7
|
L
 -3.6%
H
2.6
2.9
|
L
 -15.3%
H
2.5
3.2
|
L
 -14.2%
H
2.5
4.4
|
L
 -6.7%
H
1.8
4.4
|
L
 -72%
H
1.8
20.7
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
Dexcom Inc |
|
27,881.6
|
71.4
|
L
 0.9%
H
70.3
72.1
|
L
 -8.3%
H
68.3
74.9
|
L
 -19.9%
H
68.3
93.2
|
L
 -6.6%
H
68.3
93.2
|
L
 -45.3%
H
62.3
142
|
L
 -34.7%
H
62.3
142
|
L
 41.1%
H
45.5
164.9
|
L
 353.0%
H
10.7
164.9
|
Daxor Corp. |
|
39.3
|
8.0
|
L
 -2.6%
H
8.0
8.5
|
L
 -0.4%
H
7.7
8.5
|
L
 11%
H
7
8.5
|
L
 -5.1%
H
6.6
9.0
|
L
 -6.2%
H
6.6
10
|
L
 -27.8%
H
6.6
14.6
|
L
 -19.9%
H
6.6
24.1
|
L
 39.6%
H
3.4
24.1
|
Dynatronics Corp. |
|
0.9
|
0.1
|
L
 -16.7%
H
0.1
0.1
|
L
 -28.6%
H
0.1
0.1
|
L
 -23.1%
H
0.1
0.1
|
L
 -16.7%
H
0.1
0.2
|
L
 -76.7%
H
0.1
0.6
|
L
 -97.1%
H
0.1
4.3
|
L
 -97.9%
H
0.1
12.8
|
L
 -99.3%
H
0.1
22.2
|
ElectroCore Inc |
|
55.0
|
8.3
|
L
 -3.5%
H
7.8
9.2
|
L
 -41.4%
H
7.8
14.0
|
L
 -52.6%
H
7.8
19.5
|
L
 -42.2%
H
7.8
19.5
|
L
 24.4%
H
5.3
19.5
|
L
 6.0%
H
2.9
19.5
|
L
 12.2%
H
2.9
54.5
|
L
H
2.9
303.8
|
Ekso Bionics Holdings Inc |
|
10.7
|
0.4
|
L
 2.4%
H
0.4
0.5
|
L
 10.3%
H
0.3
0.5
|
L
 -24.6%
H
0.3
0.6
|
L
 -32.8%
H
0.3
1
|
L
 -67.4%
H
0.3
1.5
|
L
 -83.7%
H
0.3
3.2
|
L
 -84.6%
H
0.3
15.0
|
L
 -99.7%
H
0.3
245.7
|
Embecta Corp |
|
792.4
|
13.6
|
L
 3.7%
H
13.1
13.8
|
L
 6.9%
H
12.6
14.5
|
L
 -8.2%
H
12.2
15.7
|
L
 -31.8%
H
12.2
21.2
|
L
 3.0%
H
9.9
21.5
|
L
H
9.9
63
|
L
H
9.9
63
|
L
H
9.9
63
|
Establishment Labs Holding... |
|
1,132.8
|
39.3
|
L
 6.0%
H
35.9
39.4
|
L
 -5.8%
H
34.5
41.5
|
L
 8.8%
H
32.4
46.7
|
L
 -14.3%
H
28.2
47.7
|
L
 -19.9%
H
28.2
60.1
|
L
 -30.7%
H
17
93.8
|
L
 207.0%
H
7.6
93.8
|
L
H
7.6
93.8
|
Exact Sciences Corp. |
|
8,392.4
|
45.2
|
L
 0.4%
H
44.9
46.0
|
L
 -4.0%
H
42.1
47.5
|
L
 -8.4%
H
42.1
51.9
|
L
 -25.6%
H
42.1
62.2
|
L
 -21.7%
H
40.6
79.6
|
L
 -26.5%
H
29.3
100.8
|
L
 6.5%
H
29.3
159.5
|
L
 86.5%
H
4.7
159.5
|
EDAP TMS S.A. - ADR |
|
85.0
|
2.3
|
L
 1.8%
H
2.2
2.4
|
L
 -9.8%
H
2.2
2.6
|
L
 -19.9%
H
2.2
2.9
|
L
 0.9%
H
2
2.9
|
L
 -69.5%
H
2
8.5
|
L
 -69.0%
H
2
12.7
|
L
 11.2%
H
1.7
12.7
|
L
 -34.6%
H
1.4
12.7
|
GlucoTrack Inc |
|
3.9
|
0.4
|
L
 2.8%
H
0.3
0.4
|
L
H
0.3
0.5
|
L
 -24.5%
H
0.3
0.5
|
L
 -92.8%
H
0.3
7.8
|
L
 -98.8%
H
0.3
99
|
L
 -99.9%
H
0.3
424
|
L
 -99.9%
H
0.3
780
|
L
 -100.0%
H
0.3
9750
|
GE HealthCare Technologies... |
|
37,713.4
|
82.5
|
L
 0.6%
H
81.6
82.9
|
L
 -4.8%
H
80.4
89.2
|
L
 -10.6%
H
80.4
93.3
|
L
 1.2%
H
76.9
94.8
|
L
 -7.8%
H
74.5
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
Harvard Bioscience Inc. |
|
30.5
|
0.7
|
L
 7.7%
H
0.6
0.7
|
L
 -14.6%
H
0.6
0.8
|
L
 -48.2%
H
0.6
1.4
|
L
 -67.3%
H
0.6
2.3
|
L
 -82.7%
H
0.6
4.7
|
L
 -88.6%
H
0.6
6.5
|
L
 -63.9%
H
0.6
8.8
|
L
 -87.0%
H
0.6
8.8
|
Hologic, Inc. |
|
13,954.2
|
61.8
|
L
 1.8%
H
60.5
62
|
L
 -4.2%
H
60.3
66.5
|
L
 -2.3%
H
60.3
66.5
|
L
 -16.2%
H
60.3
74.3
|
L
 -18.6%
H
60.3
84.7
|
L
 -14.6%
H
59.8
87.9
|
L
 91.7%
H
26.5
87.9
|
L
 90.1%
H
26.5
87.9
|
Heart Test Laboratories Inc |
|
2.9
|
3
|
L
 2.0%
H
2.9
3
|
L
 4.2%
H
2.7
3.6
|
L
 -23.3%
H
2.6
4.1
|
L
 -22.1%
H
2.6
4.2
|
L
 -76.3%
H
2.4
13.5
|
L
H
2.4
600
|
L
H
2.4
600
|
L
H
2.4
600
|
Helius Medical Technologie... |
|
2.3
|
0.4
|
L
 -2.4%
H
0.4
0.4
|
L
 -11.1%
H
0.4
0.5
|
L
 -27.3%
H
0.4
0.6
|
L
 -18.4%
H
0.4
1.6
|
L
 -93.0%
H
0.4
7.2
|
L
 -99.7%
H
0.4
193.3
|
L
 -100.0%
H
0.4
1700
|
L
 -100.0%
H
0.4
36225
|
Hyperfine Inc - Ordinary S... |
|
99.1
|
1.3
|
L
 39.1%
H
1.1
1.4
|
L
 30.6%
H
0.9
1.4
|
L
 6.7%
H
0.9
1.4
|
L
 33.3%
H
0.9
1.9
|
L
 8.5%
H
0.8
1.9
|
L
 -57.5%
H
0.7
4.1
|
L
H
0.7
16.6
|
L
H
0.7
16.6
|
Integra Lifesciences Holdi... |
|
1,785.3
|
23.1
|
L
 3.5%
H
22.0
23.3
|
L
 0.5%
H
22.0
24.4
|
L
 -4.4%
H
21.1
25.5
|
L
 -2.5%
H
21.1
27.1
|
L
 -33.4%
H
16.8
35.5
|
L
 -64.4%
H
16.8
67.1
|
L
 -41.6%
H
16.8
77.4
|
L
 -14.5%
H
16.8
77.4
|
Icad Inc |
|
61.4
|
2.3
|
L
 1.8%
H
2.2
2.4
|
L
 4.0%
H
2.1
2.4
|
L
 -29.8%
H
2.1
3.3
|
L
 28.7%
H
1.7
3.8
|
L
 46.5%
H
1.2
3.8
|
L
 -42.8%
H
1.1
4.7
|
L
 -70.6%
H
1.1
21.4
|
L
 -75.1%
H
1.1
21.4
|
Icecure Medical Ltd |
|
86.0
|
1.5
|
L
 7.0%
H
1.4
1.5
|
L
 12.6%
H
1.3
1.5
|
L
 11.8%
H
1.3
1.7
|
L
 46.2%
H
1.0
1.7
|
L
 25.6%
H
0.5
1.7
|
L
 -36.7%
H
0.5
4.7
|
L
 18.8%
H
0.2
16
|
L
 -26.6%
H
0.2
16
|
SeaStar Medical Holding Corp |
|
18.9
|
2.2
|
L
 6.9%
H
2.0
2.2
|
L
 19.9%
H
1.7
2.2
|
L
 21.2%
H
1.5
2.2
|
L
 13.0%
H
1.5
3.1
|
L
 -89.8%
H
0.2
22.2
|
L
 -99.1%
H
0.2
550
|
L
H
0.2
550
|
L
H
0.2
550
|
ICU Medical, Inc. |
|
3,658.2
|
149.2
|
L
 4.0%
H
141.2
150.0
|
L
 5.1%
H
127.0
150.0
|
L
 -6.8%
H
127.0
165.2
|
L
 -7.5%
H
127.0
175.5
|
L
 52.1%
H
93.4
196.3
|
L
 -36.9%
H
78.4
251.7
|
L
 -6.8%
H
78.4
282
|
L
 63.0%
H
78.4
321.7
|
Idexx Laboratories, Inc. |
|
34,349.8
|
422.4
|
L
 1.7%
H
414.7
424.5
|
L
 -1.8%
H
404.6
447.4
|
L
 -5.0%
H
404.6
467.0
|
L
 -1.9%
H
404.4
474.7
|
L
 -20.3%
H
398.5
548.9
|
L
 -18.8%
H
317.1
583.4
|
L
 88.7%
H
168.7
707.0
|
L
 454.1%
H
61.4
707.0
|
Inspira Technologies Oxy B... |
|
17.2
|
0.7
|
L
 -2.7%
H
0.7
0.7
|
L
 -16.5%
H
0.7
0.8
|
L
 -21.1%
H
0.7
1.0
|
L
 -36.6%
H
0.7
1.2
|
L
 -61.8%
H
0.7
2.5
|
L
 -70.4%
H
0.7
3.2
|
L
H
0.7
9.6
|
L
H
0.7
9.6
|
Intercure Ltd |
|
75.5
|
1.6
|
L
 -1.2%
H
1.6
1.6
|
L
 -0.6%
H
1.5
1.6
|
L
 -1.2%
H
1.5
1.7
|
L
 11.9%
H
1.3
1.8
|
L
 -13.5%
H
1.2
3.7
|
L
 -76.2%
H
1.0
7.6
|
L
 -27.9%
H
1.0
12.7
|
L
H
1.0
19.4
|
Inogen Inc |
|
199.0
|
7.5
|
L
 0.7%
H
7.4
7.7
|
L
 -3.4%
H
7.3
8.2
|
L
 -29.5%
H
7.3
11.9
|
L
 -16.2%
H
7.3
12.9
|
L
 8.7%
H
6.1
13.3
|
L
 -76.8%
H
4.1
35.7
|
L
 -80.9%
H
4.1
82.4
|
L
 -77.7%
H
4.1
287.8
|
Inmode Ltd |
|
1,276.4
|
18.4
|
L
 0.2%
H
18.1
18.7
|
L
 -3.5%
H
17.7
19.8
|
L
 -2.5%
H
17.7
19.8
|
L
 0.6%
H
15.4
19.8
|
L
 -12.2%
H
14.9
21.9
|
L
 -50.8%
H
14.9
48.3
|
L
 131.7%
H
6.6
99.3
|
L
H
6.5
99.3
|
NAYA Biosciences |
|
0.9
|
0.2
|
L
 -4.8%
H
0.2
0.2
|
L
 -35.5%
H
0.2
0.4
|
L
 -42.9%
H
0.2
0.4
|
L
 -75%
H
0.2
1.0
|
L
 -80.6%
H
0.2
3.5
|
L
 -99.6%
H
0.2
56.7
|
L
 -99.9%
H
0.2
246
|
L
 -99.9%
H
0.2
953.6
|
IRIDEX Corp. |
|
17.8
|
1.1
|
L
 -5.3%
H
1.1
1.1
|
L
 -15.1%
H
1.0
1.4
|
L
 -31.0%
H
1.0
1.6
|
L
 -37.1%
H
1.0
1.9
|
L
 -55.6%
H
1.0
3.7
|
L
 -75.1%
H
1.0
5.4
|
L
 -34.4%
H
1.0
9.7
|
L
 -89.3%
H
1.0
16.6
|
Iradimed Corp |
|
662.5
|
52.1
|
L
 -0.7%
H
51.9
53.4
|
L
 -0.2%
H
50.6
53.4
|
L
 -5.7%
H
50.6
58.0
|
L
 -2.0%
H
49.6
63.3
|
L
 17.7%
H
40.2
63.3
|
L
 11.6%
H
26
63.3
|
L
 213.7%
H
14.4
63.3
|
L
 247.3%
H
7.9
63.3
|
iRhythm Technologies Inc |
|
3,257.2
|
103.7
|
L
 3.0%
H
99.0
106.0
|
L
 1.9%
H
95.5
106.0
|
L
 -7.5%
H
95.5
128.5
|
L
 14.8%
H
84.2
128.5
|
L
 1.6%
H
55.9
128.5
|
L
 -21.2%
H
55.9
169.5
|
L
 65.1%
H
41.7
286.2
|
L
H
22.2
286.2
|
Intuitive Surgical Inc |
|
174,333.9
|
488.8
|
L
 0.9%
H
474.9
495.8
|
L
 -5.7%
H
474.4
519.5
|
L
 -17.9%
H
474.4
609.1
|
L
 -9.8%
H
474.4
616
|
L
 23.4%
H
364.2
616
|
L
 75.9%
H
180.1
616
|
L
 262.7%
H
120.2
616
|
L
 768.1%
H
49.7
616
|
Kewaunee Scientific Corpor... |
|
146.6
|
51.1
|
L
 7.3%
H
46.1
52.0
|
L
 0.6%
H
42.5
53.0
|
L
 -22.7%
H
42.5
66.0
|
L
 -1.9%
H
42.5
71.3
|
L
 62.1%
H
30.9
71.3
|
L
 246.8%
H
13.6
71.3
|
L
 535.7%
H
7.0
71.3
|
L
 192.7%
H
7.0
71.3
|
OrthoPediatrics corp |
|
606.2
|
25.0
|
L
 -0.5%
H
24.7
25.4
|
L
 -1.5%
H
24.1
26.0
|
L
 1.4%
H
22.2
26.0
|
L
 12.0%
H
21.7
27.6
|
L
 -0.1%
H
21.0
36.0
|
L
 -47.8%
H
21.0
60.8
|
L
 -25.8%
H
21.0
73.9
|
L
H
14
73.9
|
KORU Medical Systems Inc |
|
136.1
|
3.0
|
L
 7.2%
H
2.8
3.0
|
L
 -6.0%
H
2.6
3.3
|
L
 -32.0%
H
2.6
4.4
|
L
 -29.3%
H
2.6
5.1
|
L
 35%
H
2.0
5.1
|
L
 4.9%
H
1.8
5.1
|
L
 -52.7%
H
1.8
12.8
|
L
 607.1%
H
0.2
12.8
|
Standard BioTools Inc |
|
443.4
|
1.2
|
L
 2.6%
H
1.1
1.2
|
L
 0.9%
H
1.1
1.2
|
L
 -17.0%
H
1.0
1.5
|
L
 -45.3%
H
1.0
2.3
|
L
 -55.3%
H
1.0
3.0
|
L
 -67.2%
H
0.9
4.2
|
L
 -51.0%
H
0.9
12.5
|
L
 -97.3%
H
0.9
46.4
|
LivaNova PLC |
|
2,250.7
|
41.4
|
L
 5.5%
H
39.4
41.7
|
L
 5.7%
H
36.9
41.7
|
L
 -13.2%
H
36.9
49.8
|
L
 -17.4%
H
36.9
52.1
|
L
 -18.2%
H
36.9
64.5
|
L
 -45.6%
H
36.9
88
|
L
 -8.2%
H
33.4
93.9
|
L
H
33.4
131.5
|
Lemaitre Vascular Inc |
|
1,920.0
|
85.1
|
L
 3.9%
H
82.0
85.5
|
L
 4.6%
H
78.8
85.5
|
L
 -13.7%
H
78.8
105.6
|
L
 -9.1%
H
78.8
105.6
|
L
 27.3%
H
62.4
109.6
|
L
 94.6%
H
38.3
109.6
|
L
 285.5%
H
18.8
109.6
|
L
 980.1%
H
7.7
109.6
|
LENSAR Inc |
|
183.7
|
15.6
|
L
 3.0%
H
14.7
15.8
|
L
 4.9%
H
12.7
15.9
|
L
 48.4%
H
9.0
16.4
|
L
 112.3%
H
7.3
16.4
|
L
 301.6%
H
2.7
16.4
|
L
 148.1%
H
1.8
16.4
|
L
H
1.8
16.4
|
L
H
1.8
16.4
|
Lantheus Holdings Inc |
|
7,036.7
|
102.8
|
L
 1.6%
H
100.2
102.9
|
L
 -3.4%
H
97.8
111.3
|
L
 28.6%
H
77.7
111.3
|
L
 9.9%
H
77.7
111.3
|
L
 76.7%
H
56.4
126.9
|
L
 86.9%
H
47.5
126.9
|
L
 853.2%
H
8.7
126.9
|
L
H
1.8
126.9
|
Lucid Diagnostics Inc |
|
122.9
|
1.5
|
L
 5.8%
H
1.3
1.5
|
L
 5.8%
H
1.2
1.5
|
L
 0.7%
H
1.2
1.6
|
L
 81.5%
H
0.8
1.6
|
L
 32.4%
H
0.6
1.6
|
L
 -54.1%
H
0.6
3.6
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
Pulmonx Corp |
|
310.0
|
7.8
|
L
 3.6%
H
7.5
7.8
|
L
 4.1%
H
7.0
7.8
|
L
 11.8%
H
6.5
9.4
|
L
 25.7%
H
5.6
9.4
|
L
 -13.0%
H
5.5
10.0
|
L
 -66.2%
H
4.1
28.3
|
L
H
4.1
69.5
|
L
H
4.1
69.5
|
Masimo Corp |
|
9,321.3
|
172.8
|
L
 2.7%
H
167.7
173.1
|
L
 -1%
H
161.0
173.1
|
L
 -4.7%
H
161.0
194.9
|
L
 -2.5%
H
161.0
194.9
|
L
 30.2%
H
101.6
194.9
|
L
 15.6%
H
75.2
198
|
L
 -0.8%
H
75.2
305.2
|
L
 445.7%
H
30.1
305.2
|
908 Devices Inc |
|
161.8
|
4.6
|
L
 10.9%
H
3.9
4.8
|
L
 65.9%
H
2.7
4.8
|
L
 64.8%
H
1.9
4.8
|
L
 106.3%
H
1.8
4.8
|
L
 -31.9%
H
1.8
7.6
|
L
 -75.2%
H
1.8
26
|
L
H
1.8
79.6
|
L
H
1.8
79.6
|
Mimedx Group Inc |
|
1,184.8
|
8.0
|
L
 1.5%
H
7.7
8.1
|
L
 1.9%
H
7.7
8.2
|
L
 -4.3%
H
7.4
8.5
|
L
 -15.1%
H
7.4
9.7
|
L
 2.0%
H
5.5
10.1
|
L
 70.3%
H
2.4
10.1
|
L
 87.0%
H
2.4
16.0
|
L
 -20.6%
H
1.0
18.3
|
Monogram Orthopaedics Inc |
|
125.9
|
3.7
|
L
 57.5%
H
2.8
4.2
|
L
 52.9%
H
2.2
4.2
|
L
 48.0%
H
2.1
4.2
|
L
 33.0%
H
2.1
4.2
|
L
 74.8%
H
1.5
4.9
|
L
H
1.5
49.0
|
L
H
1.5
49.0
|
L
H
1.5
49.0
|
Meihua International Medic... |
|
10.8
|
0.3
|
L
 6.3%
H
0.3
0.3
|
L
 6.3%
H
0.3
0.3
|
L
 3.0%
H
0.3
0.4
|
L
 -30.6%
H
0.3
0.7
|
L
 -57.5%
H
0.3
1.5
|
L
 -94.9%
H
0.3
45.5
|
L
H
0.3
45.5
|
L
H
0.3
45.5
|
Mesa Laboratories, Inc. |
|
699.1
|
128.7
|
L
 2.0%
H
125.2
129.7
|
L
 -6.5%
H
119.1
135.4
|
L
 -11.7%
H
119.1
152.0
|
L
 -3.4%
H
119.1
155.1
|
L
 27.3%
H
83.7
155.1
|
L
 -50.0%
H
82.9
268.4
|
L
 -33.2%
H
82.9
333.4
|
L
 77.5%
H
67.7
333.4
|
Merit Medical Systems, Inc. |
|
5,924.1
|
100.7
|
L
 1.8%
H
98.5
100.9
|
L
 0.7%
H
96.5
100.9
|
L
 -6.9%
H
96.5
109.8
|
L
 -1.6%
H
94.9
111.5
|
L
 40.1%
H
70.7
111.5
|
L
 60.0%
H
50.5
111.5
|
L
 288.2%
H
25.4
111.5
|
L
 413.7%
H
15.5
111.5
|
Modular Medical Inc |
|
35.4
|
0.9
|
L
 -3.3%
H
0.9
0.9
|
L
 -1.1%
H
0.8
0.9
|
L
 -20.9%
H
0.7
1.2
|
L
 -43.5%
H
0.7
1.6
|
L
 -52.5%
H
0.7
2.7
|
L
 -80.2%
H
0.7
5.4
|
L
 20.8%
H
0.7
19.5
|
L
 7.4%
H
0.6
19.5
|
Myriad Genetics, Inc. |
|
924.0
|
10.1
|
L
 0.5%
H
9.9
10.3
|
L
 -0.6%
H
9.4
11.4
|
L
 -30.5%
H
9.4
15.5
|
L
 -29.9%
H
9.4
15.5
|
L
 -52.2%
H
9.4
29.3
|
L
 -59.2%
H
9.4
29.3
|
L
 -8.1%
H
9.2
37.0
|
L
 -72.2%
H
9.2
50.4
|
MDxHealth SA - ADR |
|
-
|
1.6
|
L
 6.1%
H
1.5
1.6
|
L
 5.4%
H
1.4
1.6
|
L
 -16.0%
H
1.4
2.0
|
L
 -36.4%
H
1.4
2.5
|
L
 -41.2%
H
1.4
3.5
|
L
 -80.8%
H
1.4
11.0
|
L
H
1.4
13.2
|
L
H
1.4
13.2
|
NanoVibronix Inc |
|
2.7
|
3.4
|
L
 55.2%
H
2.8
4.2
|
L
 852.8%
H
0.2
4.2
|
L
 679.6%
H
0.2
4.2
|
L
 462.3%
H
0.2
4.2
|
L
 285.4%
H
0.2
4.2
|
L
 -76.8%
H
0.2
27.2
|
L
 -92.9%
H
0.2
83.8
|
L
H
0.2
170
|
ENDRA Life Sciences Inc |
|
2.2
|
4.1
|
L
 0.2%
H
4.1
4.3
|
L
 17.1%
H
3.2
4.3
|
L
 -18.0%
H
3.2
5.1
|
L
 -6.4%
H
3.2
7.3
|
L
 -91.8%
H
0.0
55.5
|
L
 -98.9%
H
0.0
649
|
L
 -99.5%
H
0.0
3100
|
L
H
0.0
5880
|
Neogen Corp. |
|
2,017.6
|
9.3
|
L
 2.8%
H
8.8
9.3
|
L
 -10.6%
H
8.8
10.7
|
L
 -5.4%
H
8.8
10.7
|
L
 -24.5%
H
8.8
13.4
|
L
 -38.7%
H
8.8
18.6
|
L
 -73.2%
H
8.8
35.6
|
L
 -66.1%
H
8.8
48.9
|
L
 -51.4%
H
8.8
48.9
|
Nephros Inc |
|
17.0
|
1.6
|
L
 -1.2%
H
1.5
1.7
|
L
 -2.4%
H
1.5
1.8
|
L
 5.9%
H
1.4
1.8
|
L
 3.9%
H
1.4
1.8
|
L
 -25.8%
H
1.4
2.6
|
L
 -58.7%
H
0.9
5
|
L
 -73.1%
H
0.9
11.7
|
L
 -72.9%
H
0.9
11.7
|
NeuroOne Medical Technolog... |
|
33.3
|
1.1
|
L
H
1.1
1.1
|
L
 9.1%
H
0.9
1.1
|
L
 -10%
H
0.9
1.3
|
L
 42.1%
H
0.7
1.4
|
L
 1.9%
H
0.6
1.5
|
L
 -41.6%
H
0.5
3.0
|
L
 -83.2%
H
0.5
13.5
|
L
H
0.5
30
|
Nano X Imaging Ltd |
|
341.2
|
5.8
|
L
 2.5%
H
5.7
5.9
|
L
 -3.5%
H
5.2
5.9
|
L
 -13.2%
H
5.2
7.1
|
L
 -19.0%
H
5.2
11
|
L
 -45.9%
H
5.2
12.3
|
L
 -37.3%
H
4.9
22.7
|
L
H
4.9
94.8
|
L
H
4.9
94.8
|
NeuroPace Inc |
|
366.0
|
11.2
|
L
 5.1%
H
10.6
11.5
|
L
 2.2%
H
9.6
11.5
|
L
 -8.7%
H
9.6
14.4
|
L
 -2.0%
H
9.6
15.1
|
L
 -14.7%
H
5.5
15.8
|
L
 40.5%
H
1.2
18.2
|
L
H
1.2
27.4
|
L
H
1.2
27.4
|
InspireMD Inc |
|
83.1
|
2.8
|
L
H
2.8
2.9
|
L
 -1.4%
H
2.7
3.3
|
L
 -5.1%
H
2.6
3.8
|
L
 -3.5%
H
2.4
3.8
|
L
 22.3%
H
1.8
3.8
|
L
 7.7%
H
0.8
3.9
|
L
 -62.3%
H
0.8
22.2
|
L
 -100.0%
H
0.8
2779218.8
|
Nortech Systems Inc. |
|
27.3
|
9.9
|
L
 -1.6%
H
9.7
10
|
L
 0.9%
H
9.5
10.2
|
L
 -3.0%
H
9.5
11
|
L
 -13.0%
H
9.5
12.0
|
L
 -8.8%
H
9.5
19.2
|
L
 -10.9%
H
7.5
19.6
|
L
 241.4%
H
2.5
19.6
|
L
 95.7%
H
1.7
19.6
|
Natera Inc |
|
20,176.5
|
149.3
|
L
 0.7%
H
145.1
151.8
|
L
 6.1%
H
127.8
151.8
|
L
 -13.9%
H
127.8
180.4
|
L
 -12.6%
H
127.8
183
|
L
 66.7%
H
83.1
183
|
L
 326.2%
H
27.4
183
|
L
 572.6%
H
16.9
183
|
L
H
6.5
183
|
Nutriband Inc |
|
73.0
|
6.6
|
L
 6.0%
H
6.1
6.7
|
L
 0.9%
H
6
6.8
|
L
 -7.7%
H
6
8.2
|
L
 47.6%
H
3.7
11.8
|
L
 168.2%
H
2.3
11.8
|
L
 107.3%
H
1.5
11.8
|
L
 -27%
H
0.9
27.4
|
L
H
0.9
43.5
|
Neurometrix Inc. |
|
9.1
|
4.4
|
L
 0.9%
H
4.4
4.4
|
L
 0.7%
H
4.4
4.4
|
L
 0.7%
H
4.3
4.5
|
L
 13.1%
H
3.6
4.5
|
L
 14.8%
H
2.7
4.7
|
L
 13.4%
H
0.5
5.9
|
L
 258.5%
H
0.5
38.8
|
L
 -99.2%
H
0.5
579.2
|
Nuwellis Inc |
|
5.1
|
1.2
|
L
H
1.1
1.2
|
L
 -10.8%
H
1.1
1.3
|
L
 -10.1%
H
1.1
1.5
|
L
 -2.5%
H
0.9
1.7
|
L
 -91.9%
H
0.1
16.6
|
L
 -100.0%
H
0.1
6475
|
L
 -100.0%
H
0.1
131250
|
L
 -100.0%
H
0.1
4374720000
|
NovoCure Ltd |
|
2,153.2
|
19.6
|
L
 0.5%
H
19.1
19.8
|
L
 -2.9%
H
19.1
21.6
|
L
 -12.9%
H
17.1
22.6
|
L
 -38.3%
H
17.1
34.1
|
L
 40.1%
H
11.7
34.1
|
L
 -72.6%
H
10.9
120.0
|
L
 -67.1%
H
10.9
232.8
|
L
H
6.0
232.8
|
enVVeno Medical Corporation |
|
51.9
|
3.0
|
L
 1.7%
H
2.9
3
|
L
 -3.6%
H
2.7
3.1
|
L
 -16.9%
H
2.6
3.9
|
L
 4.6%
H
2.5
3.9
|
L
 -50.3%
H
2.5
6.5
|
L
 -38.8%
H
2.5
7.9
|
L
 -64.3%
H
2.5
20.3
|
L
H
2.5
141
|
Nexalin Technology Inc |
|
31.5
|
2.4
|
L
 10.2%
H
2.2
2.5
|
L
 -0.4%
H
1.9
2.5
|
L
 -28.4%
H
1.9
3.5
|
L
 -36.1%
H
1.9
3.9
|
L
 404.3%
H
0.4
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
Nyxoah SA |
|
389.6
|
10.4
|
L
 -1.0%
H
10.3
10.7
|
L
 4%
H
9.5
11.6
|
L
 -1.1%
H
9.5
11.6
|
L
 30.1%
H
7.7
11.6
|
L
 -37.1%
H
6.8
20
|
L
 -45.6%
H
4
20.0
|
L
H
4
37
|
L
H
4
37
|
Nanobiotix - ADR |
|
158.8
|
3.4
|
L
 3.4%
H
3.2
3.5
|
L
H
3.0
3.5
|
L
 -16.9%
H
3.0
4
|
L
 -2.1%
H
2.8
4.3
|
L
 -51.8%
H
2.8
7.5
|
L
 -48.9%
H
1.8
11
|
L
H
1.8
21.6
|
L
H
1.8
21.6
|
Orchestra BioMed Holdings Inc |
|
155.8
|
4.1
|
L
 1.0%
H
4.0
4.5
|
L
 -2.6%
H
3.8
4.5
|
L
 -27.3%
H
3.8
6.0
|
L
 -19.1%
H
3.8
6.2
|
L
 -20.2%
H
3.8
8.9
|
L
 -58.3%
H
3.8
23.4
|
L
H
3.8
23.4
|
L
H
3.8
23.4
|
Orthofix Medical Inc |
|
654.8
|
16.8
|
L
 1.5%
H
16.4
16.9
|
L
 -2.2%
H
16.1
17.3
|
L
 -9.8%
H
16.1
20.5
|
L
 -6.8%
H
16.1
20.5
|
L
 22.1%
H
12.1
20.7
|
L
 -47.4%
H
9.6
35.3
|
L
 -30.1%
H
9.6
48.5
|
L
 -48.5%
H
9.6
74.4
|
Outset Medical Inc |
|
154.0
|
0.6
|
L
 5.5%
H
0.5
0.6
|
L
 -3.3%
H
0.5
0.6
|
L
 -35.6%
H
0.5
1.1
|
L
 -45.8%
H
0.5
1.7
|
L
 -73.3%
H
0.4
5.2
|
L
 -98.6%
H
0.4
48.7
|
L
H
0.4
67.0
|
L
H
0.4
67.0
|
Organogenesis Holdings Inc... |
|
630.3
|
5.0
|
L
 -0.8%
H
4.9
5.2
|
L
 -3.7%
H
4.9
5.4
|
L
 34.3%
H
3.1
6.7
|
L
 40%
H
2.9
6.7
|
L
 74.4%
H
2.2
6.7
|
L
 -36.4%
H
1.8
8.3
|
L
 26.8%
H
1.8
24.3
|
L
H
1.8
310.9
|
Orasure Technologies Inc. |
|
267.0
|
3.6
|
L
 1.7%
H
3.4
3.6
|
L
 2.3%
H
3.3
3.6
|
L
 -9.2%
H
2.7
4.1
|
L
 -10.1%
H
2.7
4.1
|
L
 -46.3%
H
2.7
7.0
|
L
 -48.1%
H
2.6
8.5
|
L
 -48.0%
H
2.6
19.8
|
L
 -50.4%
H
2.6
23.0
|
Pacific Biosciences of Cal... |
|
365.0
|
1.2
|
L
 1.6%
H
1.2
1.3
|
L
 -6.8%
H
1.2
1.5
|
L
 -33.0%
H
1.2
2.0
|
L
 -39.5%
H
1.2
2.2
|
L
 -67.3%
H
1.2
4.1
|
L
 -87.9%
H
1.2
14.6
|
L
 -49.4%
H
1.2
53.7
|
L
 -78.3%
H
1.2
53.7
|
PAVmed Inc |
|
10.4
|
0.8
|
L
 15.2%
H
0.7
0.8
|
L
 11.8%
H
0.6
0.8
|
L
 -3.8%
H
0.6
0.9
|
L
 5.6%
H
0.6
0.9
|
L
 -60.2%
H
0.6
2.8
|
L
 -39.7%
H
0.2
4.4
|
L
 -51.0%
H
0.2
9.7
|
L
H
0.2
15.2
|
Pro-Dex Inc. (co) |
|
159.4
|
48.9
|
L
 -1.6%
H
46.8
50.0
|
L
 22.0%
H
41.8
50
|
L
 38.0%
H
30.8
50
|
L
 0.9%
H
30.8
58.4
|
L
 185.1%
H
16.8
58.4
|
L
 215.2%
H
12.4
58.4
|
L
 232.6%
H
12.4
58.4
|
L
 2112.2%
H
2.0
58.4
|
PetVivo Holdings Inc |
|
12.2
|
0.6
|
L
H
0.5
0.6
|
L
 -3.5%
H
0.5
0.6
|
L
 -25.7%
H
0.5
0.7
|
L
 34.2%
H
0.4
1.0
|
L
 -45%
H
0.3
1.3
|
L
 -66.7%
H
0.3
3.6
|
L
 -32.1%
H
0.3
17
|
L
 -96.8%
H
0.2
30.4
|
Pulse Biosciences Inc |
|
987.3
|
16.1
|
L
 -5.1%
H
16.0
17.1
|
L
 -7.6%
H
16.0
17.9
|
L
 -23.5%
H
16.0
22.2
|
L
 -16.3%
H
16.0
25
|
L
 55.7%
H
6.6
25
|
L
 235.1%
H
1.2
25
|
L
 206.9%
H
1.2
45.8
|
L
H
1.2
45.8
|
Predictive Oncology Inc |
|
8.4
|
1.2
|
L
 3.6%
H
1.1
1.2
|
L
 1.8%
H
1.0
1.2
|
L
 -28.4%
H
1.0
2.0
|
L
 54.7%
H
0.7
3.1
|
L
 -56.1%
H
0.6
3.1
|
L
 -94.1%
H
0.6
22
|
L
 -96.2%
H
0.6
46
|
L
 -100.0%
H
0.6
35750
|
Precision Optics Corp., Inc. |
|
34.6
|
4.5
|
L
 0.7%
H
4.4
4.6
|
L
 -3.6%
H
4.4
4.8
|
L
 -7.7%
H
4
5.0
|
L
 -12.0%
H
4
5.3
|
L
 -22.8%
H
3.5
6.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
Insulet Corporation |
|
18,373.3
|
261.6
|
L
 2.4%
H
252.5
262.5
|
L
 3.9%
H
230.1
262.5
|
L
 -6.8%
H
230.1
289.0
|
L
 -1.5%
H
230.1
289.5
|
L
 57.7%
H
160.2
289.5
|
L
 9.6%
H
125.8
335.9
|
L
 90.6%
H
121
335.9
|
L
 634.5%
H
23.9
335.9
|
Procept BioRobotics Corp |
|
3,235.9
|
59.0
|
L
 2.5%
H
57.2
59.4
|
L
 -0.5%
H
55.1
62.9
|
L
 -12.7%
H
55.1
70.8
|
L
 -35.7%
H
55.1
90.5
|
L
 24.0%
H
45.6
103.8
|
L
 83.2%
H
24.8
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
Prenetics Global Limited -... |
|
53.1
|
4.4
|
L
 -3.8%
H
4.0
4.4
|
L
 -8.4%
H
4.0
4.8
|
L
 -19.6%
H
4.0
5.5
|
L
 -24.7%
H
4.0
6
|
L
 -7.1%
H
2.9
7.8
|
L
 -96.2%
H
2.9
131.3
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
Profound Medical Corp |
|
204.6
|
6.8
|
L
 -2.0%
H
6.7
7.0
|
L
 -0.7%
H
6.4
7.3
|
L
 1.6%
H
6.4
7.8
|
L
 -5.4%
H
5.6
8.0
|
L
 -20.1%
H
5.6
11.4
|
L
 -25.2%
H
3.1
15.5
|
L
 -26.7%
H
3.1
29.0
|
L
H
0.0
29.0
|
QuidelOrtho Corporation |
|
2,441.6
|
36.2
|
L
 0.2%
H
35.6
36.6
|
L
 -11.3%
H
35.3
41.4
|
L
 -10.8%
H
35.3
42.5
|
L
 -16.7%
H
35.3
49.5
|
L
 -25.2%
H
29.7
49.5
|
L
 -66.3%
H
29.7
120.6
|
L
 -51.2%
H
29.7
306.7
|
L
 39.2%
H
13.2
306.7
|
Quanterix Corp |
|
361.0
|
7.3
|
L
 3.1%
H
7.1
7.4
|
L
 -1.6%
H
7.0
7.8
|
L
 -9.6%
H
6.8
8.3
|
L
 -36.2%
H
6.8
12.4
|
L
 -72.6%
H
6.8
27.4
|
L
 -71.7%
H
6.3
31.3
|
L
 -48.4%
H
6.3
92.6
|
L
H
6.3
92.6
|
AVITA Medical Inc |
|
238.0
|
9.0
|
L
 5.6%
H
8.5
9.1
|
L
 8.8%
H
8.1
9.1
|
L
 -14.6%
H
8.1
11
|
L
 -27.9%
H
8.1
14.2
|
L
 -45.0%
H
7.5
16.8
|
L
 17.7%
H
4.4
21.7
|
L
 -61.7%
H
4.4
35.0
|
L
 64.2%
H
3.8
55.4
|
Rockwell Medical Inc |
|
57.2
|
1.8
|
L
 4.1%
H
1.7
1.8
|
L
 9.3%
H
1.5
1.8
|
L
 -4.3%
H
1.5
2.0
|
L
 -11.9%
H
1.5
2.4
|
L
 26.4%
H
1.4
5.2
|
L
 -54.6%
H
0.8
6.2
|
L
 -89.7%
H
0.8
33
|
L
 -98.4%
H
0.8
207.9
|
ReShape Lifesciences Inc. |
|
2.1
|
0.6
|
L
 -1.6%
H
0.6
0.7
|
L
 -30%
H
0.6
0.9
|
L
 -73.0%
H
0.6
1.9
|
L
 -86.4%
H
0.6
6.6
|
L
 -93.3%
H
0.6
29
|
L
 -100.0%
H
0.6
4466
|
L
 -100.0%
H
0.6
93699
|
L
H
0.6
1381560
|
Rewalk Robotics Ltd |
|
95.6
|
1.6
|
L
 -76.5%
H
1.5
1.6
|
L
H
1.5
1.6
|
L
H
1.5
1.6
|
L
H
1.5
1.6
|
L
H
1.5
1.6
|
L
 -78.4%
H
1.5
9.1
|
L
 -58.4%
H
1.5
42
|
L
 -99.9%
H
1.5
3045
|
Sanmina Corp |
|
4,135.2
|
76.1
|
L
 0.7%
H
75.3
77.0
|
L
 -0.2%
H
72.9
77.0
|
L
 -15.1%
H
72.9
91.1
|
L
 -5.1%
H
72.9
91.1
|
L
 27.7%
H
57.5
91.1
|
L
 84.3%
H
36.4
91.1
|
L
 306.2%
H
18.4
91.1
|
L
 215.3%
H
16.3
91.1
|
Sight Sciences Inc |
|
142.7
|
2.8
|
L
 2.2%
H
2.6
2.8
|
L
 17.8%
H
2.3
2.9
|
L
 1.5%
H
2.2
2.9
|
L
 -23.8%
H
2.2
3.7
|
L
 -38.1%
H
2.2
8.5
|
L
 -80.4%
H
1.0
15.9
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
Sotera Health Co |
|
3,381.8
|
11.9
|
L
 2.9%
H
11.6
12.0
|
L
 -1.9%
H
11.1
12.2
|
L
 -11.5%
H
11.1
14.0
|
L
 -8.2%
H
11.1
14
|
L
 -17.8%
H
10.7
17.1
|
L
 -40.7%
H
5.8
24.9
|
L
H
5.8
30.4
|
L
H
5.8
30.4
|
SI-BONE Inc |
|
646.1
|
15.2
|
L
 3.2%
H
14.6
15.3
|
L
 -5.2%
H
14.6
16.8
|
L
 -7.1%
H
14.6
19.2
|
L
 10.5%
H
12.8
19.2
|
L
 -5.1%
H
11.7
19.2
|
L
 -24.2%
H
11.1
29.5
|
L
 27.4%
H
7.2
37.2
|
L
H
7.2
37.2
|
SINTX Technologies Inc |
|
8.7
|
3.1
|
L
 -8.8%
H
3.0
3.4
|
L
 -5.7%
H
3.0
3.6
|
L
 5.8%
H
2.8
7.4
|
L
 3.0%
H
2.8
7.4
|
L
 -87.5%
H
0.1
45.6
|
L
 -100.0%
H
0.1
14160
|
L
 -100.0%
H
0.1
68800
|
L
 -100.0%
H
0.1
90612000
|
Beauty Health Company (The... |
|
165.3
|
1.3
|
L
H
1.3
1.4
|
L
 1.5%
H
1.2
1.6
|
L
 -21.0%
H
1.1
1.7
|
L
 -15.4%
H
1.1
1.9
|
L
 -63.4%
H
0.9
4.6
|
L
 -92.3%
H
0.9
19.4
|
L
H
0.9
30.2
|
L
H
0.9
30.2
|
Semler Scientific Inc |
|
345.8
|
36.0
|
L
 4.9%
H
33.5
36.6
|
L
 -3.1%
H
32
36.6
|
L
 -27.5%
H
32
53.9
|
L
 -51.8%
H
32
81.6
|
L
 18.7%
H
20.9
81.6
|
L
 -27.2%
H
19.1
81.6
|
L
 -1.0%
H
19.1
153.2
|
L
 666.6%
H
1.1
153.2
|
Sanara MedTech Inc |
|
287.6
|
32.9
|
L
 1.6%
H
32.5
33.3
|
L
 -0.3%
H
30.6
33.3
|
L
 -6.1%
H
30.6
36.3
|
L
 -4.0%
H
30.6
38.7
|
L
 -11.1%
H
26
39.1
|
L
 19.2%
H
17.4
50.2
|
L
 196.4%
H
7.0
53.9
|
L
 448.3%
H
2
75
|
Surmodics, Inc. |
|
414.7
|
29.0
|
L
 2.5%
H
28.3
29.4
|
L
 -1.2%
H
26.6
30.4
|
L
 -14.9%
H
26.6
36
|
L
 -27.4%
H
26.6
40.2
|
L
 3.0%
H
25.2
42.4
|
L
 -31.4%
H
16
45.9
|
L
 29.2%
H
16
62.3
|
L
 12.1%
H
16
82.4
|
Sensus Healthcare Inc |
|
80.2
|
4.9
|
L
 4.5%
H
4.7
5.0
|
L
 5.7%
H
4.3
5.0
|
L
 -11.8%
H
4.3
5.9
|
L
 -39.0%
H
4.3
9.1
|
L
 38.1%
H
3.1
9.3
|
L
 -53.2%
H
1.8
15.3
|
L
 62%
H
1.8
15.3
|
L
H
1.8
15.3
|
STRATA Skin Sciences Inc |
|
11.0
|
2.6
|
L
 -5.4%
H
2.6
2.8
|
L
 2.7%
H
2.5
2.9
|
L
 -4.4%
H
2.5
2.9
|
L
 -12.0%
H
2.5
3.3
|
L
 -46.2%
H
2.5
41
|
L
 -82.1%
H
2.5
41
|
L
 -73.2%
H
2.5
41
|
L
 -98.5%
H
2.5
187
|
Staar Surgical Co. |
|
869.1
|
17.6
|
L
 3.3%
H
17.1
18.0
|
L
 -3.9%
H
17.0
20.5
|
L
 14.8%
H
15.2
20.5
|
L
 -28.7%
H
13.5
25.9
|
L
 -53.3%
H
13.5
52.7
|
L
 -73.9%
H
13.5
112.3
|
L
 -29.5%
H
13.5
163.1
|
L
 144.4%
H
5.0
163.1
|
Neuronetics Inc |
|
328.3
|
5.1
|
L
 12.0%
H
4.5
5.1
|
L
 -0.2%
H
4.2
5.1
|
L
 16.1%
H
3.8
5.9
|
L
 364.2%
H
1.1
5.9
|
L
 29.7%
H
0.5
5.9
|
L
 60.6%
H
0.5
7.0
|
L
 160.8%
H
0.5
22.4
|
L
H
0.5
39.4
|
Star Equity Holdings Inc |
|
7.0
|
2.2
|
L
 0.5%
H
2.2
2.4
|
L
 -2.7%
H
2.1
2.4
|
L
 0.9%
H
2.1
2.5
|
L
 -11.3%
H
2.1
2.6
|
L
 -51.7%
H
2.1
5.4
|
L
 -61.7%
H
2.1
8.0
|
L
 -89.7%
H
2.1
27
|
L
 -99.0%
H
2.1
346
|
Sharps Technology Inc |
|
3.7
|
0.3
|
L
 -2.9%
H
0.3
0.4
|
L
 10%
H
0.3
0.7
|
L
 -5.7%
H
0.3
0.7
|
L
 -84.4%
H
0.3
2.3
|
L
 3.1%
H
0.1
4.2
|
L
H
0.1
4.2
|
L
H
0.1
4.2
|
L
H
0.1
4.2
|
Tactile Systems Technology... |
|
319.1
|
13.5
|
L
 2.8%
H
13
13.5
|
L
 -4.7%
H
13
14.2
|
L
 -21.9%
H
13
18.1
|
L
 -24.4%
H
13
18.5
|
L
 -19.2%
H
11.1
21.1
|
L
 -22.7%
H
6.3
26.1
|
L
 -61.1%
H
6.3
64.5
|
L
H
6.3
76.6
|
TELA Bio Inc |
|
95.7
|
2.4
|
L
 3.4%
H
2.3
2.5
|
L
 0.4%
H
2.2
2.5
|
L
 -6.9%
H
2.2
3.0
|
L
 -12.9%
H
2.2
3.1
|
L
 -54.4%
H
2.2
6.5
|
L
 -79.4%
H
2.2
13.2
|
L
 -73.4%
H
2.2
23.5
|
L
H
2.2
23.5
|
Tivic Health Systems Inc |
|
2.0
|
3.3
|
L
 0.3%
H
3.1
3.6
|
L
 -11.3%
H
2.9
3.9
|
L
 -66.0%
H
2.9
10.0
|
L
 -10.8%
H
2.9
15.6
|
L
 -84.6%
H
2.9
31.5
|
L
 -99.9%
H
2.9
4879
|
L
H
2.9
11050
|
L
H
2.9
11050
|
Treace Medical Concepts Inc |
|
499.1
|
8.0
|
L
 0.3%
H
7.9
8.2
|
L
 -7%
H
7.8
8.7
|
L
 -20.9%
H
7.8
10.3
|
L
 5.0%
H
6.7
10.8
|
L
 -32.9%
H
3.9
13.2
|
L
 -58.6%
H
3.9
28.0
|
L
H
3.9
37.2
|
L
H
3.9
37.2
|
Transmedics Group Inc |
|
2,278.6
|
67.7
|
L
 -1.2%
H
67.2
69.7
|
L
 0.3%
H
62.6
69.7
|
L
 -6.2%
H
62.1
80.2
|
L
 4.1%
H
55
82.4
|
L
 -10.9%
H
55
177.4
|
L
 252.2%
H
19.5
177.4
|
L
 544.7%
H
10
177.4
|
L
H
10
177.4
|
Tandem Diabetes Care Inc |
|
1,310.2
|
19.7
|
L
 2.8%
H
19.2
20.1
|
L
 9.7%
H
17.6
20.1
|
L
 -41.1%
H
17.6
35.1
|
L
 -40.6%
H
17.6
38.3
|
L
 -31.1%
H
17.6
53.7
|
L
 -82.0%
H
13.8
124.0
|
L
 -58.9%
H
13.8
155.9
|
L
 -85.4%
H
2.1
155.9
|
Trinity Biotech Plc - ADR |
|
18.7
|
0.7
|
L
H
0.7
0.7
|
L
 -1.5%
H
0.7
0.8
|
L
 -10.5%
H
0.6
0.9
|
L
 -24.4%
H
0.6
1.5
|
L
 -69.6%
H
0.6
3.6
|
L
 -32%
H
0.4
3.6
|
L
 -19.0%
H
0.4
6.8
|
L
 -96.4%
H
0.4
19.7
|
Utah Medical Products, Inc. |
|
193.2
|
57.9
|
L
 1.1%
H
56.8
58
|
L
 -1.4%
H
56.8
60.5
|
L
 -5.1%
H
56.8
61.7
|
L
 -8.0%
H
56.8
65.6
|
L
 -16.4%
H
56.8
77.3
|
L
 -33.9%
H
56.8
109.5
|
L
 -27.8%
H
56.8
133.9
|
L
 -3.3%
H
50
133.9
|
Vivani Medical Inc |
|
65.2
|
1.1
|
L
 0.9%
H
1.1
1.1
|
L
 1.9%
H
1.0
1.1
|
L
 -6.0%
H
1.0
1.2
|
L
 -16.0%
H
1.0
1.3
|
L
 -44.2%
H
1.0
2.2
|
L
 -70.4%
H
0.8
8.1
|
L
 -86.7%
H
0.8
60
|
L
 -99.6%
H
0.8
420
|
Veracyte Inc |
|
2,434.2
|
31.2
|
L
 -0.9%
H
31.2
32.2
|
L
 -2.5%
H
30.2
32.3
|
L
 -24.0%
H
30.1
42.3
|
L
 -27.9%
H
30.1
47.3
|
L
 48.0%
H
18.6
47.3
|
L
 20.2%
H
14.9
47.3
|
L
 66.6%
H
13.9
86.0
|
L
 308.2%
H
4.2
86.0
|
Venus Concept Inc |
|
1.9
|
2.9
|
L
 7.6%
H
2.6
2.9
|
L
 -5.9%
H
2.6
3.3
|
L
 763.6%
H
0.3
3.9
|
L
 763.6%
H
0.3
3.9
|
L
 307.1%
H
0.3
3.9
|
L
 -86.0%
H
0.3
24.3
|
L
 -94.1%
H
0.3
88.5
|
L
H
0.3
2688.8
|
Varex Imaging Corp |
|
528.6
|
12.8
|
L
 2.6%
H
12.4
12.9
|
L
 0.1%
H
12.1
13.0
|
L
 -3.4%
H
12.1
13.6
|
L
 -15.6%
H
11.8
15.5
|
L
 -26.7%
H
10.2
18.3
|
L
 -44.9%
H
10.2
23.9
|
L
 -30.2%
H
10.2
32.7
|
L
H
10.2
43.8
|
Vivos Therapeutics Inc |
|
21.1
|
3.6
|
L
 8.5%
H
3.3
3.7
|
L
 -3.0%
H
3.1
3.7
|
L
 -10.5%
H
3.0
4.2
|
L
 -31.2%
H
3.0
6.3
|
L
 -20.4%
H
1.9
6.3
|
L
 -94.6%
H
1.9
74.1
|
L
H
1.9
360.3
|
L
H
1.9
360.3
|
Wrap Technologies Inc |
|
110.5
|
2.3
|
L
 -0.4%
H
2.2
2.4
|
L
 6.6%
H
1.9
2.4
|
L
 5.6%
H
1.7
2.6
|
L
 31.6%
H
1.5
2.6
|
L
 -21.6%
H
1.2
2.9
|
L
 8.7%
H
1.0
7.0
|
L
 -42.0%
H
1.0
14.4
|
L
H
1.0
14.4
|
Beyond Air Inc |
|
26.5
|
0.3
|
L
 11.1%
H
0.3
0.3
|
L
 15.4%
H
0.2
0.3
|
L
 -23.1%
H
0.2
0.4
|
L
 -34.8%
H
0.2
0.6
|
L
 -80.5%
H
0.2
1.8
|
L
 -95.5%
H
0.2
11.8
|
L
 -94.2%
H
0.2
16.4
|
L
H
0.2
45
|
DENTSPLY Sirona Inc |
|
3,102.3
|
15.6
|
L
 0.2%
H
15.4
15.9
|
L
 -4.5%
H
14.8
16.4
|
L
 -14.9%
H
14.8
19.3
|
L
 -20.4%
H
14.8
20.6
|
L
 -52.5%
H
14.8
33.7
|
L
 -67.9%
H
14.8
50.6
|
L
 -55.7%
H
14.8
69.5
|
L
 -69.4%
H
14.8
69.5
|
X.T.L. Biopharmaceuticals ... |
|
11.3
|
1.3
|
L
H
1.3
1.3
|
L
 2.4%
H
1.2
1.4
|
L
 -26.4%
H
1.2
1.6
|
L
 -23.4%
H
1.2
2.3
|
L
 45.5%
H
1.0
5.0
|
L
 -41.6%
H
0.8
5.0
|
L
 21.9%
H
0.6
6.7
|
L
 -89.2%
H
0.6
12.8
|
ZimVie Inc |
|
337.9
|
12.2
|
L
 1.4%
H
12.1
12.5
|
L
 -2.7%
H
11.7
12.9
|
L
 -7.1%
H
11.7
13.8
|
L
 -11.1%
H
11.7
15.3
|
L
 -25.9%
H
11.7
22.3
|
L
 -46.6%
H
5.1
28.9
|
L
H
5.1
50.4
|
L
H
5.1
50.4
|
Jin Medical International Ltd |
|
139.3
|
0.9
|
L
 4.7%
H
0.8
0.9
|
L
 11.3%
H
0.7
0.9
|
L
 3.5%
H
0.6
0.9
|
L
 15.6%
H
0.6
1.3
|
L
 -79.7%
H
0.6
4.7
|
L
H
0.6
509.9
|
L
H
0.6
509.9
|
L
H
0.6
509.9
|
Zynex Inc |
|
92.5
|
2.9
|
L
 -2.4%
H
2.9
3.1
|
L
 -60.5%
H
2.8
7.3
|
L
 -61.5%
H
2.8
7.7
|
L
 -65.7%
H
2.8
8.7
|
L
 -76.9%
H
2.8
13.2
|
L
 -46.0%
H
2.8
17.3
|
L
 -65.9%
H
2.8
27.0
|
L
 2316.7%
H
0.1
27.0
|
HeartBeam Inc |
|
71.2
|
2.1
|
L
 2.9%
H
2.0
2.2
|
L
 -3.7%
H
2
2.2
|
L
 -0.9%
H
1.9
2.4
|
L
 -20.4%
H
1.9
2.8
|
L
 -12.5%
H
1.7
3.5
|
L
 33.5%
H
1.4
3.5
|
L
 33.5%
H
1.4
3.5
|
L
 33.5%
H
1.4
3.5
|
Incannex Healthcare Limite... |
|
13.2
|
0.7
|
L
H
0.7
0.8
|
L
 -14.9%
H
0.7
0.9
|
L
 -58.4%
H
0.7
1.8
|
L
 -61.1%
H
0.7
2.3
|
L
 -76.3%
H
0.7
3.6
|
L
 -86.5%
H
0.7
5.3
|
L
 -86.5%
H
0.7
5.3
|
L
 -86.5%
H
0.7
5.3
|
Rewalk Robotics Ltd. |
|
16.9
|
1.6
|
L
 5.3%
H
1.5
1.6
|
L
 -2.5%
H
1.3
3.0
|
L
 -27.1%
H
1.3
3.0
|
L
 3.3%
H
1.3
4
|
L
 -66.3%
H
1.3
6
|
L
 -78.4%
H
1.3
9.1
|
L
 -58.4%
H
1.3
42
|
L
 -99.9%
H
1.3
3045
|
Xylo Technologies Ltd. - ADR |
|
3.5
|
4.7
|
L
 -6.0%
H
4.6
5.4
|
L
 -5.2%
H
4.5
5.7
|
L
 -2.3%
H
3.6
5.7
|
L
 39.4%
H
3.1
5.7
|
L
 -34.2%
H
2.7
17.8
|
L
 -99.3%
H
2.7
720
|
L
 -99.3%
H
2.7
3090
|
L
H
2.7
4963200
|
Work Medical Technology Gr... |
|
9.0
|
0.6
|
L
 -3.1%
H
0.6
0.6
|
L
 -7.5%
H
0.6
0.7
|
L
 -72.8%
H
0.6
6
|
L
 -87.8%
H
0.6
6
|
L
H
0.6
8.5
|
L
H
0.6
8.5
|
L
H
0.6
8.5
|
L
H
0.6
8.5
|
Pheton Holdings Ltd. - Ord... |
|
52.3
|
3.7
|
L
 -12.2%
H
3.6
4.2
|
L
 59.6%
H
2.1
4.3
|
L
 39.5%
H
1.3
5
|
L
 -8.3%
H
1.3
5
|
L
H
1.3
6.5
|
L
H
1.3
6.5
|
L
H
1.3
6.5
|
L
H
1.3
6.5
|
Ceribell Inc. |
|
734.2
|
20.5
|
L
 -2.7%
H
20.4
22.1
|
L
 -9.8%
H
20.4
23.3
|
L
 -4.5%
H
20.4
26.0
|
L
 -30.3%
H
18.7
29.7
|
L
H
17
32.8
|
L
H
17
32.8
|
L
H
17
32.8
|
L
H
17
32.8
|
Anteris Technologies Globa... |
|
241.5
|
6.7
|
L
 -2.0%
H
6.6
7.1
|
L
 -11.1%
H
6.5
7.9
|
L
 -15.9%
H
6.5
8.8
|
L
 22.2%
H
5.3
8.8
|
L
H
5.1
8.8
|
L
H
5.1
8.8
|
L
H
5.1
8.8
|
L
H
5.1
8.8
|
Beta Bionics Inc. |
|
719.8
|
16.6
|
L
 13.2%
H
14.6
17.1
|
L
 2.9%
H
13.6
17.1
|
L
 -23.8%
H
13.6
22.3
|
L
H
13.6
24.5
|
L
H
13.6
24.5
|
L
H
13.6
24.5
|
L
H
13.6
24.5
|
L
H
13.6
24.5
|
Kestra Medical Technologie... |
|
1,227.4
|
24.8
|
L
 16.5%
H
21.3
25.4
|
L
 18.1%
H
20
25.4
|
L
H
20
25.4
|
L
H
20
25.4
|
L
H
20
25.4
|
L
H
20
25.4
|
L
H
20
25.4
|
L
H
20
25.4
|
Sanuwave Health Inc |
|
-
|
31.8
|
L
 10.4%
H
28.7
32.4
|
L
H
27.6
32.4
|
L
H
27.6
32.4
|
L
H
27.6
32.4
|
L
H
27.6
32.4
|
L
H
27.6
32.4
|
L
H
27.6
32.4
|
L
H
27.6
32.4
|